Background Misconceptions about ADHD stigmatize affected people, reduce credibility of
providers, and prevent/delay treatment. To challenge misconceptions, we curated findings …

Objective Nonpharmacological treatments are available for attention deficit hyperactivity
disorder (ADHD), although their efficacy remains uncertain. The authors undertook meta …

Attention-deficit hyperactivity disorder (ADHD) is a common childhood behavioural disorder.
Systematic reviews indicate that the community prevalence globally is between 2% and 7 …

Background Major depressive disorder is one of the most common mental disorders in
children and adolescents. However, whether to use pharmacological interventions in this …

Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …

Background The validity of clinical guidelines changes over time, because new
evidencebased knowledge and experience develop. Objective Hence, the European clinical …

Quality of life (QoL) describes an individual's subjective perception of their position in life as
evidenced by their physical, psychological, and social functioning. QoL has become an …

A systematic review of published and unpublished data on the use of long-acting
medications in ADHD and hyperkinetic disorder is reported, giving effect sizes and numbers …

The safety of ADHD medications is not fully known. Concerns have arisen about both a lack
of contemporary-standard information about medications first licensed several decades ago …

1 Ochoa TJ, Sizonenko SV. Lactoferrin and prematurity: a promising milk protein? Biochem
Cell Biol 2017; 95: 22-30. 2 Tarnow-Mordi W et al, Abdel-Latif ME, Martin A, et al. The effect …